中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

43 records (took 0.014 seconds)

    Evaporation cell for vacuum evaporation chamber and associated evaporation method
    1.
    发明授权
    Evaporation cell for vacuum evaporation chamber and associated evaporation method 有权

    公开(公告)号：US11685988B2

    公开(公告)日：2023-06-27

    申请号：US17070246

    申请日：2020-10-14

    Applicant: RIBER

    Inventor： Jean-Louis Guyaux ,  Franck Stemmelen ,  Youri Rousseau

    IPC: C23C14/24 ,  C23C14/26 ,  C23C14/06

    CPC classification number: C23C14/243 ,  C23C14/0694 ,  C23C14/24

    Abstract: The invention relates to an evaporation cell (1) for vacuum evaporation chamber, the evaporation cell (1) comprising a crucible (5), the crucible (5) being adapted to receive a solid or liquid material to be sublimated or evaporated, heating means (3) to heat the material in the crucible, a nozzle (6) placed at an open end of the crucible (5), the nozzle (6) comprising a frustoconical portion (61) having an opening (60) adapted for the passage of a flow of evaporated or sublimated material towards the vacuum evaporation chamber, and a cover (7) placed on the nozzle (6), the cover (7) having an opening (70) arranged about the frustoconical portion (61) of the nozzle (6). According to the invention, the cover (7) has at least one frustoconical portion (71, 72, 73) arranged about the frustoconical portion (61) of the nozzle (6), the cover (7) forming a thermal barrier between the crucible (5) and the vacuum evaporation chamber.

    EVAPORATION CELL
    6.
    发明申请
    EVAPORATION CELL 审中-公开
    蒸发细胞

    公开(公告)号：US20150307984A1

    公开(公告)日：2015-10-29

    申请号：US14694164

    申请日：2015-04-23

    Applicant: RIBER

    Inventor： David ESTEVE ,  Franck STEMMELEN

    IPC: C23C14/24

    CPC classification number: C23C14/243 ,  C23C14/246 ,  C23C14/26 ,  C23C14/542 ,  C23C14/56 ,  C23C14/564

    Abstract: An evaporation cell for evaporating a material onto a substrate placed in a vacuum deposition chamber, includes an inner enclosure delimiting an evaporation chamber for receiving a crucible containing the material and having an opening for inserting the crucible into the evaporation chamber; evaporation elements placed at the periphery of the inner enclosure for placing the crucible in evaporation conditions; an injection duct for transporting a flow of vapour of the evaporated material from the evaporation chamber to an injector located in the vacuum deposition chamber; and a stop valve placed on the injection duct. The evaporation cell includes insertion opening/shutting elements that have an open configuration for inserting the crucible into the evaporation chamber, and a closed configuration for confining the evaporation chamber in communication with the vacuum deposition chamber via the injection duct, and opening elements to provide an evaporation opening in an envelope of the crucible.

    Abstract translation: 用于将材料蒸发到放置在真空沉积室中的基板上的蒸发单元包括限定蒸发室的内部外壳，用于接纳含有该材料的坩埚，并具有用于将坩埚插入蒸发室的开口; 放置在内壳周边的蒸发元件将坩埚置于蒸发条件下; 用于将蒸发的材料的蒸汽流从蒸发室输送到位于真空沉积室中的喷射器的注入管道; 和一个放置在注射管上的截止阀。 蒸发单元包括具有用于将坩埚插入蒸发室的打开构造的插入开/关元件，以及用于限制蒸发室经由注入管道与真空沉积室连通的关闭构造，以及开启元件以提供 在坩埚的封套内的蒸发开口。

    Glucagon analogues
    8.
    发明授权
    Glucagon analogues 有权
    胰高血糖素类似物

    公开(公告)号：US08642540B2

    公开(公告)日：2014-02-04

    申请号：US13139482

    申请日：2008-12-15

    Applicant: Eddi Meier ,  Ditte Riber ,  Marie Skovgaard ,  Bjarne Due Larsen ,  Jens Rosengren Daugaard

    Inventor： Eddi Meier ,  Ditte Riber ,  Marie Skovgaard ,  Bjarne Due Larsen ,  Jens Rosengren Daugaard

    IPC: A61K38/00 ,  A61K38/22 ,  A61K38/26

    CPC classification number: C07K14/605 ,  A61K38/00

    Abstract: The invention provides materials and methods for promoting weight loss or preventing weight gain, and in the treatment of diabetes, metablic syndrome and associated disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

    Abstract translation: 本发明提供了用于促进体重减轻或预防体重增加以及治疗糖尿病，代谢综合征和相关疾病的材料和方法。 特别地，本发明提供了在这些方法中有效的新型胰高血糖素类似物肽。 与人胰高血糖素相比，肽可以通过增加对GLP-1受体的选择性而介导其作用。

    GLUCAGON ANALOGUES
    9.
    发明申请
    GLUCAGON ANALOGUES 有权

    公开(公告)号：US20130157935A1

    公开(公告)日：2013-06-20

    申请号：US13702841

    申请日：2011-06-23

    Applicant: Eddi Meier ,  Ditte Riber ,  Jens Rosengren Daugaard ,  Marie Skovgaard

    Inventor： Eddi Meier ,  Ditte Riber ,  Jens Rosengren Daugaard ,  Marie Skovgaard

    IPC: C07K14/605 ,  A61K45/06 ,  A61K38/26

    CPC classification number: C07K14/605 ,  A61K38/26 ,  A61K45/06

    Abstract: The invention provides materials and methods for promoting weight loss or preventing weight gain without affecting glycemic control. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

    Abstract translation: 本发明提供用于促进体重减轻或预防体重增加而不影响血糖控制的材料和方法。 特别地，本发明提供了在这些方法中有效的新型胰高血糖素类似物肽。 与人胰高血糖素相比，肽可以通过增加对GLP-1受体的选择性而介导其作用。

    Glucagon analogues
    10.
    发明授权
    Glucagon analogues 有权
    胰高血糖素类似物

    公开(公告)号：US07994122B2

    公开(公告)日：2011-08-09

    申请号：US12664534

    申请日：2008-06-16

    Applicant: Ditte Riber ,  Eddi Meier ,  Trine Skovlund Ryge ,  Jens Rosengren Daugaard

    Inventor： Ditte Riber ,  Eddi Meier ,  Trine Skovlund Ryge ,  Jens Rosengren Daugaard

    IPC: A61K38/26

    CPC classification number: C07K14/605

    Abstract: The invention provides materials and methods for promoting weight loss or preventing weight gain in a subject. In particular, the invention provides novel glucagon analogue peptides effective in such methods and in the treatment of obesity, eating disorders, metabolic syndrome, and non-alcoholic liver steatosis. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

    Abstract translation: 本发明提供用于促进体重减轻或预防受试者体重增加的材料和方法。 特别地，本发明提供了在这些方法和治疗肥胖症，进食障碍，代谢综合征和非酒精性肝脂肪变性中有效的新型胰高血糖素类似物肽。 与人胰高血糖素相比，肽可以通过增加对GLP-1受体的选择性而介导其作用。

Patent Agency Ranking